NPI: 1215904776 · HIALEAH, FL 33010 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/03/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,636 | $1.56M |
| 2019 | 23,810 | $2.43M |
| 2020 | 22,398 | $3.11M |
| 2021 | 18,850 | $1.32M |
| 2022 | 14,409 | $1.57M |
| 2023 | 768 | $87K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,895 | 1,752 | $3.18M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 32,015 | 1,274 | $2.99M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,608 | 957 | $1.48M |
| A4657 | Syringe, with or without needle, each | 4,114 | 1,485 | $897K |
| J1756 | Injection, iron sucrose, 1 mg | 6,310 | 1,130 | $630K |
| 85048 | 1,736 | 1,009 | $160K | |
| 85041 | 1,735 | 1,009 | $160K | |
| 83970 | 1,197 | 677 | $126K | |
| 83540 | 1,213 | 710 | $125K | |
| 83550 | 1,213 | 710 | $125K | |
| 82728 | 1,130 | 657 | $118K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 251 | 81 | $33K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 154 | 92 | $19K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 146 | 54 | $18K |
| 82108 | 108 | 62 | $17K | |
| 90674 | 15 | 12 | $4K | |
| G0008 | Administration of influenza virus vaccine | 31 | 25 | $2K |